Controlling Myopia Progression With Soft Contact Lenses
- Conditions
- Myopia
- Interventions
- Device: Active ComparatorDevice: Test Soft Contact Lens CDevice: Test Soft Contact Lens B
- Registration Number
- NCT01787760
- Lead Sponsor
- Johnson & Johnson Vision Care, Inc.
- Brief Summary
This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 221
- The subject must be between 8 and 12 years of age and of Asia origin.
- The subject's best sphere contact lens correction must lie between -0.75D (best of the two eyes) and -5.00D (worst of the two eyes)
- Astigmatism must be less than or equal to 1.00D
- Less than 1.00D difference in spherical equivalent between the two eyes
- The subject must have a best-corrected visual acuity of 20/25 and spherical equivalent refraction visual acuity of 20/25 or better in both eyes
- The subject must have at least 8D of accommodation.
- The subject's parent or legal guardian must read and sign the STATEMENT OF INFORMED CONSENT and the subject must read and sign the Child's Assent Form and be provided a copy of each form
- The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol
- Ocular or systemic allergies or diseases that may interfere with contact lens wear
- Systemic disease or autoimmune disease or use of medication (e.g. antihistamines), which may interfere with contact lens wear.
- Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that might interfere with contact lens wear.
- Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormality of the cornea, which may contraindicate contact lens wear.
- Any ocular infection.
- Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
- Any infectious disease (e.g. hepatitis, tuberculosis) or immunosuppressive disease (e.g. HIV).
- Diabetes.
- Anismetropia.
- Astigmatism of greater than 1.00D in either eye.
- Eye injury or eye surgery within eight weeks immediately prior to enrollment for this study.
- Previous refractive surgery, rigid contact lens wear, orthokeratology, keratoconus, or other corneal irregularity in either eye
- Strabismus in either eye
- Pupil or lid abnormality or infection in either eye
- Central corneal scar and aphakia in either eye
- Contraindications to contact lens wear such as dry eye or history of prior unsuccessful contact lens wear
- History of participation in clinical trials aimed to control myopia progression
- Surgically altered eyes, ocular infection of any type, ocular inflammation
- Subject has anterior chamber angle grade 2 or narrower
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Spectacle Lenses Active Comparator Control spectacle lenses worn daily. Test Soft Contact Lens C Test Soft Contact Lens C Lenses will be worn in a daily disposable modality Test Soft Contact Lens B Test Soft Contact Lens B Lenses will be worn in a daily disposable modality
- Primary Outcome Measures
Name Time Method Axial Length (Axial Elongation) Baseline and every 6 months post-baseline up to 3 years Axial Length was measured with the IOLMaster at baseline, and then every 6 months throughout the course of the study. Five measurements were collected for each eye at each visit and the average of the 5 measurements were used for the analysis. Higher values of axial elongation indicate worse vision.
Spherical Equivalent Refraction Baseline and every 6 months post-baseline up to 3 years Spherical Equivalent Refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 3 repeated measurements, each of which was the average of 3 consecutive readings, was used for the analysis. Higher values of spherical refraction indicate progression in Myopia.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Hong Kong Polytechnic University
🇭🇰Hung Hom, Kowloon, Hong Kong
The Hong Kong Polytechnic University🇭🇰Hung Hom, Kowloon, Hong Kong